Late-life depression: a silent epidemic
Journal Title: Journal of Geriatric Care and Research - Year 2017, Vol 4, Issue 2
Abstract
Late life depression is extremely common, but it is often missed or undertreated even in secondary care. It affects not only the morbidity and mortality, but also has negative impact on prognosis of many illnesses. It is associated with most old age suicides which are on the rise. It cannot be overemphasized that depression in elderly needs to identified and appropriately treated. There are screening questions which can be used at all levels of health and social care, which can clarify need for further assessment. There are effective intervention strategies which can be provided even at a primary care level. In summary, efforts should be taken so that older adults with depression are identified early and adequately treated.
Authors and Affiliations
Nilamadhab Kar
Translation of Recovering Quality of Life (ReQoL) to Hindi: addressing linguistic issues
The linguistic validation process of the Recovering Quality of Life (ReQoL) scale to Hindi, the national language of India, was undertaken by a team of mental health professionals at Post Graduate Institute of Medical Sc...
Edentulism in elderly: a review of current clinical concerns in India
Background: Edentulism is one of the public health burdens for elderly people; as about 30% of the elderly population aged over 65 years is edentulous across the globe. There is a significant rise in the demographic grow...
Physician assisted death in the UK: decision making on a debatable issue
The majority of the British public support medically assisted suicide. However, it remains illegal under British criminal law despite several attempts to legalize it. The uncertainty of medical opinion has impacted on th...
Views of old age psychiatrists on use of community treatment orders in ageing population in England and Wales - a pilot study
Background: Community Treatment orders (CTO) were introduced in England and Wales during the 2008 reformation of mental health legislation. There is scant research evidence regarding the use of CTOs with older adults (pe...
Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer’s disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity
Background: The donepezil-memantine combination is a US Food and Drug Administration (FDA)–approved medication to treat Alzheimer’s disease (AD). Galantamine is superior to donepezil because it is a positive allosteric m...